Suraksha Diagnostic CEO, MD, chairman, board of directors and AGM

Mutual fund votes, meeting of 5 Sep 2025, 6 fund houses

• To receive, consider and adopt the audited (standalone and consolidated) financial statements of the Company for the financial year ended 31 March 2025 together with the Report of the Board of Directors’ and Auditors’ thereon.MoreLess

  ›Against Motilal Oswal Mutual Fund

  • Motilal Oswal Mutual FundUnqualified Financial Statements (except for minor observations in the CARO Report). Non-Compliant with Companies Act, 2013 & SEBI LODR Regulations: The Company has not disclosed financial statements of a subsidiary for FY 2024-25 on its website.

  5 for1 against
• To appoint Directors in place of Dr. Somnath Chatterjee (DIN: 00137075), Chairman & Joint Managing Director and Ms. Ritu Mittal (DIN: 00165886), Joint Managing Director & CEO of the Company, who retires by rotation and being eligible, offers themselves for re-appointmentMoreLess

  ›Against Motilal Oswal Mutual Fund

  • Motilal Oswal Mutual FundNo concern identified on the merits of the proposed appointees. Governance Concern w.r.t. Dr Somnath Chatterjee holding combined position of Chairman and Managing Director, may lead to concentration of power in the hand of single person. Compliance Concern: The Company has clubbed the resolution of re-appointment of Dr. Somnath Chatterjee and Ms. Ritu Mittal, without complying section 162 of the Companies Act 2013.

  5 for1 against
• Approval for Appointment of Secretarial Auditor

  ›Against Motilal Oswal Mutual Fund, Nippon India Mutual Fund

  • Motilal Oswal Mutual FundCompliant with law. No justification for the material changes in the proposed Audit remuneration.
  • Nippon India Mutual FundTransparency Concern: No justification for the material changes in the proposed Audit remuneration.

  4 for2 against
• Ratification of remuneration payable to M/s. S. Chhaparia & Associates, Cost Auditor for Financial Year Ending 31 March 2026

  6 for0 against

Mutual fund votes, meeting of 8 Feb 2025, 7 fund houses

• RATIFICATION OF ‘SURAKSHA EMPLOYEE STOCK OPTION SCHEME 2024’ (ESOP 2024/ SCHEME)

  ›Against Bandhan Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Nippon India Mutual Fund, quant Mutual Fund

  • Bandhan Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Inadequate disclosures regarding the Exercise Price.
  • Kotak Mahindra Mutual FundWe take note of the determination of the Exercise Price on a specific date. However, as per the Company, the NRC is still empowered to grant options from time to time, to employees at an exercise price, to be determined at the time of grant. As a result, the determination of the Exercise price on a specific date is in no way indicative of the Exercise Price or a Pricing formula under the Scheme. In absence of adequate clarification, voting against.
  • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
  • Nippon India Mutual FundInadequate disclosures regarding the Exercise Price.
  • quant Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Inadequate disclosures regarding the Exercise Price. The intent behind SEBI mandating such disclosures in the Notice is that, the shareholders could estimate the economic benefit proposed to be transferred to its employees during the course of time. Non-disclosure or authorizing Board to decide such particulars defeats the purpose of SEBI requiring Companies to disclose such information. Such unfettered powers and open-ended provisions defeat the entire purpose of having the scheme approved by the shareholders and are against the principles of good corporate governance. While, we note the determination of the Exercise Price on a specific date, it is also noted that, as per the Company, the NRC is still empowered to grant options from time to time, to employees at an exercise price, to be determined at the time of grant. As a result, the determination of the Exercise price on a specific date is in no way indicative of the Exercise Price or a Pricing formula under the Scheme.

  2 for5 against

• Fine or penaltyNational Stock Exchange of India LimitedSince 31 Aug 2026

  NSE issued a notice dated August 31, 2026 regarding delay of 1 day in submission of the quarterly shareholding pattern (SHP) under Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended June 2026 on the NSE portal, and levied fine of Rs. 2,000/- + GST therefor.

  Delay of one day in submission of the SHP under Regulation 31(1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on NSE portal for the quarter ended June 30, 2026.

In the company's own words, from its latest governance filing.

The board is made up as the listing rules require

Yes

The board has a regular chairperson

Yes

The company has a risk management committee

No

The chair is related to the managing director

Yes

The filing has a part on fines and penalties

Yes

The filing has a part on tax disputes

No

There was a cyber security incident in the quarter

No

The company's own answers in its filing.